DNMT3A and mature T-cell and NK-cell non-Hodgkin lymphoma: For instance, ALCL showed no mutations in TET2 and only one (1/12, 8%) mutation in DNMT3A, a finding that might help in the differential diagnosis between this entity and cases of PTCL, NOS, where TET2 mutations were relatively frequent (6/21, 29%).